Sagility India IPO Details
| IPO Issue Open Date: | 5 November 2024 |
| IPO Issue Close Date: | 7 November 2024 |
| IPO Issue Price Band: | ₹28 to ₹30 Per Share |
| Face Value: | ₹10 Per Equity Share |
| IPO Issue Size: | ₹2,106.60 Crores | 702,199,262 shares |
| Fresh Issue: | ₹2,106.60 Crores | 702,199,262 shares |
| Offer for Sale: | ₹2,106.60 Crores |
| Issue Type: | Book Built Issue |
| IPO Listing At: | BSE, NSE |
| IPO Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| Employee Discount: | ₹[.] per share |
Sagility India IPO Prospectus:
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
Sagility India IPO Dates Timeline
| Issue Open Date: | 5 November 2024 |
| Issue Close Date: | 7 November 2024 |
| Basis of Allotment Date: | 8 November 2024 |
| Refunds Initiation: | 8 November 2024 |
| Shares Credit in Demat: | 11 November 2024 |
| IPO Listing Date Detail: | 12 November 2024 |
Sagility India IPO Market Lot
| Application | Lot Size, Shares and Price Details |
| Retail (Min) | 1 lots and 500 shares = ₹15,000 |
| Retail (Max) | 13 lots and 6500 shares = ₹195,000 |
| HNI (Min) | 14 lots and 7,000 shares = ₹210,000 |
| B-HNI Minimum | 67 lots and 33,500 shares = ₹1,005,000 |
Sagility India IPO GMP*
| GMP Date | GMP Today | Subject to Sauda | Kostak | Expected Gain |
| Today | ₹- | ₹- | ₹- | ₹- |
About Sagility India
Sagility India is a technology-enabled, pure-play healthcare-focused solutions and services provider to Payers (U.S. health insurance companies, which finance and reimburse the cost of health services), and Providers (primarily hospitals, physicians, and diagnostic and medical devices companies). They support the core business operations of both Payer and Provider clients. Their services to Payers encompass the entire spectrum of their operations, including core benefits administration functions and clinical services. These services include claims management, payment integrity, clinical management, and other services. To Providers, They provide revenue cycle management services which help them manage their billings and claim the cost of treatment from Payers. Additionally, we also provide some of the services that they provide to payers and pharmacy benefit managers (“PBMs”) who manage prescription drugs for members (i.e., insured persons) under health insurance plans. They deliver these services leveraging their tools and platforms, as needed, through their capable talent pool from our five global service delivery locations in India, the Philippines, the U.S., Jamaica, and Colombia.
Sagility India IPO Strengths
To Be Updated Soon
Objects of the IPO Issue
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges, and
- Carry out the Offer for Sale of up to 984,460,377 Equity Shares of the face value of Rs. 10 each by the Promoter Selling Shareholder.
Sagility India Company Financial Report
The company reported revenue of ₹4,781.5 crores in 2024 against ₹4,236.06 crores in 2023. The company reported a profit of ₹228.27 crores in 2024 against a loss of ₹143.57 crores in 2023.
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2022 | ₹944.39 | ₹733.82 | ₹4.67 | ₹10,096.28 |
| 2023 | ₹4,236.06 | ₹3,191.20 | ₹143.57 | ₹10,590.48 |
| 2024 | ₹4,781.5 | ₹3,665.47 | ₹228.27 | ₹10,664.2 |
Sagility India IPO Valuation – Key Performance Indicator
Check Sagility India IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | -% |
| ROCE: | -% |
| EBITDA Margin: | 23.48% |
| PAT Margin: | 12.40% |
| Debt to equity ratio: | 0.34 |
| Earning Per Share (EPS): | ₹0.53 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 3.54% |
| Net Asset Value (NAV): | ₹15.03 |
Peer Group Comparison
The below peer comparison table’s data are showing as per the DRHP and RHP.
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| NA | NA | NA | NA | NA | – Cr. |
Sagility India IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: sagility.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
Sagility India IPO Lead Manager
- ICICI Securities Limited
- Iifl Securities Ltd
- Jefferies India Private Limited
- J.P. Morgan India Private Limited
Sagility India IPO allotment status check on Link Intime website. Click on Link Intime India Private Ltd to get allotment status.
Promoters of Sagility India
- Sagility B.V
- Sagility Holdings B.V
Company Address
Sagility India Limited
No. 23 & 24, AMR Tech Park,
Building 2A, First Floor, Hongasandara Village,
Off Hosur Road, Bommanahalli, Bengaluru – 560 068
Phone: +91- 80-7125 150
Email: investorservice@sagilityhealth.com
Website: http://www.sagilityhealth.com/